Presentation Information
[Pj-076-6]Clinical characteristics of Natalizumab-related progressive multifocal leukoencephalopathy in Japan
Kazuya Takahashi1,2, The Japanese PML surveillance committee2 (1.Department of Medicine, NHO Iou National Hospital, Japan, 2.The Japanese PML surveillance committee, Japan)